Generative AI in drug development
by Giuliana Miglierini Generative AI is perhaps the more advanced form of artificial intelligence available today, as it…
ACT EU’s Workplan 2022-2026
by Giuliana Miglierini The implementation phase of the Accelerating Clinical Trials in the EU (ACT EU) initiative, launched…